
Meridian Bioscience VIVO
Quarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience Cash Conversion Cycle 2011-2026 | VIVO
Annual Cash Conversion Cycle Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 201 | 232 | 206 | 208 | 212 | 215 | 250 | 195 | 201 | 208 | 199 | 221 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 250 | 195 | 212 |
Quarterly Cash Conversion Cycle Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 266 | - | - | 163 | 194 | - | 283 | 245 | 186 | 118 | 198 | 159 | 225 | 113 | 213 | 220 | 220 | 108 | 222 | 215 | 209 | 107 | 215 | 45 | 50.1 | 52.6 | 48.8 | 53.3 | 52.1 | 50.9 | 49.7 | 48.2 | 44.5 | 45.4 | 44.9 | 43.5 | 49.6 | 48.8 | 50.7 | 50.9 | 48.3 | 50.8 | 52.6 | 48.5 | 55.6 | 54.8 | 56.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 283 | 43.5 | 115 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
111 | $ 118.88 | -0.73 % | $ 36.1 B | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 19.95 | -2.97 % | $ 215 M | ||
|
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 21.35 | 21.51 % | $ 1.14 B | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-2.46 K | $ 1.41 | -0.5 % | $ 1.88 M | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 24.45 | -0.69 % | $ 679 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 181.78 | 0.62 % | $ 9.01 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
77.5 | $ 194.57 | -1.78 % | $ 139 B | ||
|
Interpace Biosciences
IDXG
|
62.9 | $ 2.15 | -2.45 % | $ 9.51 M | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 524.75 | 1.2 % | $ 15.1 B | ||
|
Illumina
ILMN
|
142 | $ 131.47 | -0.6 % | $ 20.9 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 16.25 | 0.46 % | $ 491 M | ||
|
NeoGenomics
NEO
|
82.4 | $ 8.38 | -3.51 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
150 | $ 9.31 | -1.17 % | $ 2.02 B | ||
|
Guardant Health
GH
|
79.6 | $ 85.85 | 1.17 % | $ 10.8 B | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 29.01 | -0.21 % | $ 20 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.85 | -2.73 % | $ 92.5 K | ||
|
Biomerica
BMRA
|
172 | $ 2.2 | 4.27 % | $ 5.05 M | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 117.72 | 1.04 % | $ 9.71 B | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 269.19 | 0.86 % | $ 22.4 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Senseonics Holdings
SENS
|
36.1 | $ 6.78 | -1.74 % | $ 283 M | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 5.16 | -0.58 % | $ 478 M | ||
|
Soleno Therapeutics
SLNO
|
-398 | $ 52.6 | 0.05 % | $ 2.67 B | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 83.21 | -0.87 % | $ 5.62 B | ||
|
Neuronetics
STIM
|
17.3 | $ 1.38 | -1.08 % | $ 91 M | ||
|
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 194.16 | 1.48 % | $ 21.6 B | ||
|
ENDRA Life Sciences
NDRA
|
-1.24 K | $ 5.13 | -0.19 % | $ 4.04 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 522.3 | -1.73 % | $ 197 B | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.71 | 1.07 % | $ 61.9 M | ||
|
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M |